• HOME
  • NEWS
  • EXPLORE
    • CAREER
      • Companies
      • Jobs
    • EVENTS
    • iGEM
      • News
      • Team
    • PHOTOS
    • VIDEO
    • WIKI
  • BLOG
  • COMMUNITY
    • FACEBOOK
    • INSTAGRAM
    • TWITTER
Thursday, April 2, 2026
BIOENGINEER.ORG
No Result
View All Result
  • Login
  • HOME
  • NEWS
  • EXPLORE
    • CAREER
      • Companies
      • Jobs
        • Lecturer
        • PhD Studentship
        • Postdoc
        • Research Assistant
    • EVENTS
    • iGEM
      • News
      • Team
    • PHOTOS
    • VIDEO
    • WIKI
  • BLOG
  • COMMUNITY
    • FACEBOOK
    • INSTAGRAM
    • TWITTER
  • HOME
  • NEWS
  • EXPLORE
    • CAREER
      • Companies
      • Jobs
        • Lecturer
        • PhD Studentship
        • Postdoc
        • Research Assistant
    • EVENTS
    • iGEM
      • News
      • Team
    • PHOTOS
    • VIDEO
    • WIKI
  • BLOG
  • COMMUNITY
    • FACEBOOK
    • INSTAGRAM
    • TWITTER
No Result
View All Result
Bioengineer.org
No Result
View All Result
Home NEWS Science News Biology

Antibiotics from a ‘molecular pencil sharpener’

Bioengineer by Bioengineer
October 24, 2017
in Biology
Reading Time: 3 mins read
0
Share on FacebookShare on TwitterShare on LinkedinShare on RedditShare on Telegram
IMAGE

Credit: Dmitry Ghilarov/Skolkovo Institute of Science and Technology and David Lawson/John Innes Centre

Picture a brand-new, unsharpened pencil. The graphite at its core can't be used for writing until a pencil sharpener chews away its wooden tip.

Now picture microcin B17, an antibiotic that kills E. coli bacteria. Before being activated, it lies embedded in a structure called a prodrug, like the core of an unsharpened "molecular pencil."

Now, for the first time, scientists at Rutgers University-New Brunswick and other institutions have discovered a "molecular pencil sharpener" that chews away its outer coating to release the powerful antibiotic. Their discovery opens the door to finding new antibacterial agents and drugs to fight toxins.

"We think this may be a gizmo that bacteria use to activate processes which are dormant until the moment is right, when the pencil sharpener gets turned on and releases antibiotics," said Konstantin Severinov, senior author of a new study and principal investigator in the Waksman Institute of Microbiology at Rutgers University-New Brunswick.

The scientists, whose discovery was published in the journal Structure, studied TldD and TldE bacterial proteins involved in making microcin B17.

Many bacterial cells make inactive compounds called prodrugs – precursors that turn into drugs in the body, Severinov said.

"It's like a future drug and when the need arises and when the going gets tough, the drug is activated and it's like a toxic warhead that gets exported outside the cell and kills its harmful neighbors," he said.

The prodrug examined by the scientists is like a stick with two parts, he said. The core part is the toxic warhead. A "leader" is on the other end and prevents the warhead from functioning until the right time.

"TldD, the protein we studied, has a hole in it just like in an old pencil sharpener, where the prodrug is fed into," Severinov said. "The sharpener adds the last finishing touch, chewing the leader, activating the toxic warhead and kicking it out of the cell. So it's almost like having an ability to produce toxic compounds, including antibiotics, a la carte when you need them."

Tld genes are common in bacteria, suggesting that they play an important function in bacterial physiology, the study says. That might include a role in protein quality control and activating different natural products including antibiotics, such as microcin B17.

"Every bacterial genome sequenced to date has Tld genes," Severinov said. "Nobody knew what they do, and now we know what they do in one case, and we think that similar functions activate the production of bioactive compounds used by other bacteria as antibiotics or toxins."

Some toxins could be used in a beneficial way, he noted. For example, people have been using bacterial toxins to kill insects for decades. And when bacteria produce toxins that harm humans, drugs that inhibit Tld and fight such bacteria could be developed.

The scientists speculate that their findings could lead to future applications in the protein engineering and synthetic biology fields.

###

Media Contact

Todd B. Bates
[email protected]
848-932-0550
@RutgersU

http://www.rutgers.edu

Original Source

https://news.rutgers.edu/antibiotics-%E2%80%98molecular-pencil-sharpener%E2%80%99/20171018#.WejH-FtSy70 http://dx.doi.org/10.1016/j.str.2017.08.006

Share12Tweet8Share2ShareShareShare2

Related Posts

Newly Discovered Chronic Pain Circuit Unveils Potential Avenues for Innovative Treatments

Newly Discovered Chronic Pain Circuit Unveils Potential Avenues for Innovative Treatments

April 2, 2026
DNA Transforms from Blueprint to Active Field Agent

DNA Transforms from Blueprint to Active Field Agent

April 2, 2026

UBC Okanagan Study Reveals How Trees Visually Signal Their Spring Rehydration

April 1, 2026

Rising Temperatures from Climate Change Associated with Reduced Newborn Size

April 1, 2026
Please login to join discussion

POPULAR NEWS

  • blank

    Revolutionary AI Model Enhances Precision in Detecting Food Contamination

    96 shares
    Share 38 Tweet 24
  • Imagine a Social Media Feed That Challenges Your Views Instead of Reinforcing Them

    1007 shares
    Share 398 Tweet 249
  • Promising Outcomes from First Clinical Trials of Gene Regulation in Epilepsy

    51 shares
    Share 20 Tweet 13
  • Popular Anti-Aging Compound Linked to Damage in Corpus Callosum, Study Finds

    44 shares
    Share 18 Tweet 11

About

We bring you the latest biotechnology news from best research centers and universities around the world. Check our website.

Follow us

Recent News

Flu Vaccine May Shield Against Heart Attack and Stroke, Even in Those Who Contract the Virus

Breakthrough in Room-Temperature Drying Provides Affordable Method to Stabilize Functional Proteins

First-in-Class Dual HIF Inhibitors Eradicate Breast, Colorectal, Melanoma, and Prostate Tumors in Mice Combined with Immunotherapy

Subscribe to Blog via Email

Enter your email address to subscribe to this blog and receive notifications of new posts by email.

Join 78 other subscribers
  • Contact Us

Bioengineer.org © Copyright 2023 All Rights Reserved.

Welcome Back!

Login to your account below

Forgotten Password?

Retrieve your password

Please enter your username or email address to reset your password.

Log In
No Result
View All Result
  • Homepages
    • Home Page 1
    • Home Page 2
  • News
  • National
  • Business
  • Health
  • Lifestyle
  • Science

Bioengineer.org © Copyright 2023 All Rights Reserved.